Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
GigNet Announces Agreement to Provide High-Speed Broadband to Grupo Xcaret Parks and Hotels in the Mexican Caribbean
-
NASA Sets Coverage for U.S. Spacewalk 90 Outside Space Station
-
XAI Octagon Floating Rate & Alternative Income Trust Announces Agreement for Private Placement of Convertible Preferred Shares
-
Readymag Simplifies Domain Purchase and Connection Process with Entri
-
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Cruz Closes $225,000 Listed Issuer Financing Exemption (LIFE) Private Placement
-
Rio Tinto to acquire Mitsubishi’s 11.65% stake in Boyne aluminium smelter
-
Spirit Advisors Opens New Branch Office in Tokyo to Serve Japanese Clients
-
Montauk Metals Announces Arbitration Decision in Claim Against Colombia
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Inquire About Securities Class Action Investigation – AIXI
-
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Perion Network Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PERI
-
Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
-
True Exposure Investments, Inc. lowers management fee for series F of the TruX Exogenous Risk Pool and refiles Management Report of Fund Performance and Fund Facts documents for 2023
-
Tharimmune Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis
-
Jumia Opens New Integrated Warehouses in Lagos, Nigeria and Casablanca, Morocco
-
Top Rhodesian Ridgeback Breeder Utilizes AI to Enhance Operations and Animal Care
-
Peraso To Participate at the 16th Annual CEO Investor Summit 2024
-
Top SEO Company in Texas Integrating AI into Businesses
-
Tharimmune Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis
-
JAMESTOWN SETTLEMENT'S SUSAN CONSTANT TO EMBARK ON MULTIYEAR RESTORATION
-
Tharimmune Announces Positive Results of Phase 1 Trial in Healthy Subjects with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Primary Biliary Cholangitis
-
Sixth Street Lending Partners Prices Offering of $150 million 6.500% Notes due 2029
-
Torex Gold Outlines Multi-Year Exploration Strategy
-
NexPoint Diversified Real Estate Trust Releases Investor Presentation
-
Wolters Kluwer Reports Significant Uptake in adoption of BEPS Pillar Two Initiative Among Multinational Corporations
-
GICAI launches revolutionary global digital currency quantitative trading platform to improve investment returns and security
-
KBRA Assigns Preliminary Ratings to OBX 2024-NQM9 Trust
-
Kelly Liggett Takes the Helm of No Barriers as Executive Director
-
Virginia Natural Gas fuels workforce development with $620,000 investment
-
FLYHT Announces Closing of $5 Million Unsecured Debenture Arrangement
-
The Empire State Building Unveils Exclusive “House of the Dragon” Takeover at the Iconic Observatory Experience, in Partnership with Max
-
Adalberto Sanchez, 1 Other Injured in Multi-Vehicle Truck Accident on I.H. 35
-
Take-Two Interactive Software, Inc. Announces Pricing of $600 Million Senior Notes Offering
-
End of the BAPE Public Information Period
-
Jumia Opens New Integrated Warehouses in Lagos, Nigeria and Casablanca, Morocco
-
Kinetic Seas f/k/a Bellatora announces completion of Phase I of its data center for AI
-
NUTRATIVA™ GLOBAL, NORTHERN LIGHTS FOOD PROCESSING AND PALMER HOLLAND HEALTH & NUTRITION JOIN FORCES TO PROMOTE SPECIALTY INGREDIENTS FROM CRANBERRIES
-
Apple extends its privacy leadership with new updates across its platforms
-
NASA Awards Contract for Safety and Mission Assurance Services
-
Bird to Acquire B.C.-Based Civil Infrastructure Contractor for $135 Million, Expects Resulting 10% Full Year Adj. EPS Accretion
-
NV Gold Announces Amended Triple T Property Lease Agreement
-
Ballard Publishes its 2023 ESG Report
-
Empower Healthcare Solutions and DispatchHealth® collaborate to bring in-home urgent medical care to Central Arkansas
-
SmartStop Self Storage REIT Announces National Self Storage Day on June 10, 2024
-
ALZHEIMER'S DRUG DISCOVERY FOUNDATION'S (ADDF) STATEMENT ON FDA ADVISORY COMMITTEE'S ENDORSEMENT OF DONANEMAB
-
ZimCal Urges All Stockholders to Vote for Its Board Candidates Before the June 11th, 2024 Shareholder Meeting
-
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis
-
InMed to Present at the Emerging Growth Conference
-
ALZHEIMER'S ASSOCIATION WELCOMES FDA ADVISORY COMMITTEE UNANIMOUS VOTE OF EFFICACY OF DONANEMAB FOR THE TREATMENT OF EARLY ALZHEIMER'S DISEASE
-
Firm Capital Mortgage Investment Corporation Announces Election of Directors
